COGNITA LABS, LLC — Department of Health and Human Services STTR Phase I: DESCRIPTION (provided by applicant): Respiratory illnesses continue to be on the rise1-4,
COGNITA LABS, LLC — STTR Phase I award from Department of Health and Human Services.
- Amount
- $223,042
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- STTR · Phase I
- Solicitation
- PA14-072
- NAICS
- —
- Place of performance
- TX
- Period
- —
Description
DESCRIPTION (provided by applicant): Respiratory illnesses continue to be on the rise1-4, in particular, COPD alone impacts nearly 210 million globally 6. Metered Dose Inhaler (MDI) is the most common mechanism to deliver medicine, and is used by the patients for both maintenance and rescue medications. It is well established that regular use of the medications minimizes long-term damage to the lungs, and results in improved health outcomes for the patients 7. Unfortunately, nearly 70-90% of the patients donot display correct technique11-17 and nearly 50% do not take their medications regularly 8-10,13. The biggest challenge in correct use lies in the difficulty of using the inhaler. Correct inhaler is akin to shooting at a small target at the ight time i.e. patients have to point the inhaler towards the back of their throat and activate the inhaler at the correct time during their inhalation - a maneuver which turns out to be difficult fo most patients to master. To compound the problem, regular use